BioPhorum Supply Chain to Patient
BioPhorum Supply Chain to Patient is developing resilient and agile supply chains that consistently deliver high-quality medicines to patients. Our members are working to create a transparent patient-centric, end-to-end supply chain to ensure an uninterrupted supply to our patients through industry collaboration.
The biopharmaceutical industry plays a crucial role in delivering life-saving medications, vaccines, and therapies to patients worldwide, however the current outbound supply chain, designed around a blockbuster model, no longer suits the evolving pipeline and emerging modalities. Recent challenges, including the COVID-19 pandemic, geopolitical events, ultra-low-temperature transport, and environmental concerns tied to new sustainability regulations, underline the need for a more agile, resilient, cost-effective, patient-centric supply chain. The complex nature of the outbound supply chain necessitates industry collaboration amongst biopharmaceutical manufacturers, 3Pls, and partner organizations to make a meaningful change.
To meet the demands of the future, the supply chain must undergo a continuous evolution, striving for greater agility and adaptability, all while maintaining strict regulatory compliance and minimizing our ecological footprint.
During the development of a Strategic Framework that spotlights five key objectives for a successful supply chain, several areas for collaboration have been acknowledged. With a need for greater industry benchmarking, the team is developing a maturity tool to assess a company’s supply chain against the framework’s five objectives. The data will then be used to develop business cases for investment, drive focus, and benchmark against peers.
Standardization, particularly for cell and gene therapy products, will allow for a more agile supply chain. Engaging with patients at the start of a transformation is crucial to enable the industry to build a patient-centric supply chain. By inviting regulators, and healthcare providers to collaborate we can drive innovation within the supply chain and refine processes in areas such as direct-to-patient shipping.
The potential to propel the biopharma supply chain forward into the future is vast.
The Strategic Framework is a reference for the biopharmaceutical industry, enabling organizations to align with industry trends, reassess their priorities, and plan future developments. BioPhorum Supply Chain to Patient will use the Framework objectives to evaluate its program and ensure alignment with industry goals, fostering focused collaboration:
- Data-driven decision-making: fully digital integrated supply chain enabled by accurate real-time information
- Uninterrupted, cost-effective, agile supply chain: ensuring continuity of supply in an adaptable and cost-effective manner
- Sustainable and responsible: sustainable supply chain with minimized impact on the planet
- Dynamic and skilled workforce: diverse workforce supported by ongoing training and development opportunities
- Drive innovation through collaboration: engaging with regulators, healthcare and patients to drive innovation and industry collaboration.
Contact BioPhorum Supply Chain to Patient
To find out more about how BioPhorum BioPhorum Supply Chain to Patient can help your business, enter your details below and a member of our team will be in touch.